Jung‐Yi Lin

497 total citations
15 papers, 263 citations indexed

About

Jung‐Yi Lin is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jung‐Yi Lin has authored 15 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Psychiatry and Mental health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jung‐Yi Lin's work include Pharmacological Effects and Toxicity Studies (6 papers), Epilepsy research and treatment (5 papers) and Glioma Diagnosis and Treatment (2 papers). Jung‐Yi Lin is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Epilepsy research and treatment (5 papers) and Glioma Diagnosis and Treatment (2 papers). Jung‐Yi Lin collaborates with scholars based in United States, Germany and Canada. Jung‐Yi Lin's co-authors include Umut Özbek, Myron Schwartz, Max W. Sung, Andrea D. Branch, Sirish Dharmapuri, Celina Ang, Caroline C. Friedel, Jessica Tomé-García, Igor Katsyv and Nadejda M. Tsankova and has published in prestigious journals such as Epilepsia, BMC Health Services Research and Oral Oncology.

In The Last Decade

Jung‐Yi Lin

14 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jung‐Yi Lin United States	6	125	57	57	52	46	15	263
Liangfang Shen China	13	163 1.3×	24 0.4×	55 1.0×	61 1.2×	28 0.6×	36	466
Mi Hwa Heo South Korea	12	148 1.2×	18 0.3×	26 0.5×	31 0.6×	14 0.3×	28	262
Saroona Haroon Pakistan	10	67 0.5×	29 0.5×	51 0.9×	25 0.5×	9 0.2×	40	343
Claudio Codignola Italy	9	203 1.6×	22 0.4×	41 0.7×	24 0.5×	17 0.4×	27	270
Linda Heijmen Netherlands	10	87 0.7×	9 0.2×	39 0.7×	27 0.5×	51 1.1×	25	326
Florencia Moreno Argentina	9	70 0.6×	14 0.2×	37 0.6×	49 0.9×	7 0.2×	16	248
Sheshadri Madhusudhana United States	7	67 0.5×	15 0.3×	99 1.7×	43 0.8×	8 0.2×	22	234
Jonathan Whisenant United States	11	219 1.8×	10 0.2×	46 0.8×	65 1.3×	22 0.5×	26	336
Cornelius Maihöfer Germany	5	92 0.7×	37 0.6×	23 0.4×	47 0.9×	3 0.1×	6	290
Zhenyu Huo China	10	75 0.6×	17 0.3×	35 0.6×	26 0.5×	4 0.1×	36	236

Countries citing papers authored by Jung‐Yi Lin

Since Specialization

Citations

This map shows the geographic impact of Jung‐Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Yi Lin more than expected).

Fields of papers citing papers by Jung‐Yi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Yi Lin. The network helps show where Jung‐Yi Lin may publish in the future.

Co-authorship network of co-authors of Jung‐Yi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Yi Lin. A scholar is included among the top collaborators of Jung‐Yi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Yi Lin. Jung‐Yi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Goldstein, Jonathan, Heng‐Ming Tai, Jung‐Yi Lin, et al.. (2025). Development and validation of International Classification of Diseases, 9th and 10th Revision, Clinical Modification‐based algorithms to identify adult epilepsy in electronic health records. Epilepsia. 66(9). 3334–3343.

Brown, Stacey-Ann Whittaker, Camelia Iancu‐Rubin, Elizabeth Burke, et al.. (2022). Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019. Cytotherapy. 24(8). 835–840. 7 indexed citations

Lin, Jung‐Yi, Churl‐Su Kwon, Madhu Mazumdar, et al.. (2021). Postpartum psychiatric readmissions: A nationwide study in women with and without epilepsy. Epilepsia. 62(5). 1148–1157. 3 indexed citations

Coltoff, Alexander, et al.. (2021). Evaluating Race and Time to Transplantation in Multiple Myeloma: The Mount Sinai Hospital Experience. Clinical Lymphoma Myeloma & Leukemia. 21(7). 439–443. 2 indexed citations

Lin, Jung‐Yi, et al.. (2021). Hospital readmissions in older adults with epilepsy in the US – A population-based study. Epilepsy & Behavior. 122. 108167–108167. 3 indexed citations

Lin, Jung‐Yi, et al.. (2021). The co-occurrence of dementia in those with epilepsy is associated with 30-day readmission – A population-based study. Epilepsy & Behavior. 122. 108126–108126. 3 indexed citations

Bhalla, Sheena, Huili Zhu, Jung‐Yi Lin, et al.. (2021). Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers. Cancer Reports. 4(6). e1412–e1412. 4 indexed citations

Dharmapuri, Sirish, Umut Özbek, Jung‐Yi Lin, et al.. (2020). Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy. Cancer Medicine. 9(14). 4962–4970. 82 indexed citations

Mazumdar, Madhu, Jung‐Yi Lin, Wei Zhang, et al.. (2020). Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data. BMC Health Services Research. 20(1). 350–350. 34 indexed citations

10.

Jetté, Nathalie, et al.. (2020). A nationally representative study on discharge against medical advice among those living with epilepsy. Seizure. 84. 84–90. 2 indexed citations

11.

Zhong, Xiaobo, Jung‐Yi Lin, Lihua Li, et al.. (2020). Derivation and validation of a novel comorbidity‐based delirium risk index to predict postoperative delirium using national administrative healthcare database. Health Services Research. 56(1). 154–165. 5 indexed citations

12.

Sindhu, Kunal K., Amanda Leiter, Erin Moshier, et al.. (2020). Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade. Cancer Treatment and Research Communications. 25. 100216–100216. 10 indexed citations

13.

Kwon, Churl‐Su, Bonnie O. Wong, Jung‐Yi Lin, et al.. (2020). Nonelective hospital admissions, discharge disposition, and health services utilization in epilepsy patients: A population‐based study. Epilepsia. 61(9). 1969–1978. 5 indexed citations

14.

Smith, William H., Lucas Resende Salgado, Bethann Scarborough, et al.. (2019). Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies. Oral Oncology. 92. 1–5. 15 indexed citations

15.

Tejero, Rut, Yong Huang, Igor Katsyv, et al.. (2019). Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment. EBioMedicine. 42. 252–269. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact